fluoxetine has been researched along with nan 190 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buck, LB; Petrascheck, M; Ye, X | 1 |
Gean, PW; Lu, KT | 1 |
Clements, S; Moore, FL; Schreck, CB | 1 |
Hu, Y; Huang, XY; Luo, CX; Wu, DL; Wu, HY; Ye, ML; Zhang, J; Zhou, QG; Zhu, DY; Zhu, LJ | 1 |
Costa, EA; Da Rocha, FF; Fajemiroye, JO; Florentino, IF; Galdino, PM; Ghedini, PC; Polepally, PR; Zjawiony, JK | 1 |
5 other study(ies) available for fluoxetine and nan 190
Article | Year |
---|---|
An antidepressant that extends lifespan in adult Caenorhabditis elegans.
Topics: Aging; Animals; Antidepressive Agents; Caenorhabditis elegans; Caloric Restriction; Humans; Longevity; Methiothepin; Mianserin; Octopamine; Receptors, Biogenic Amine; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin 5-HT4 Receptor Antagonists; Serotonin Antagonists; Signal Transduction; Starvation | 2007 |
Endogenous serotonin inhibits epileptiform activity in rat hippocampal CA1 neurons via 5-hydroxytryptamine1A receptor activation.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Barium; Epilepsy; Excitatory Postsynaptic Potentials; Fluoxetine; Hippocampus; In Vitro Techniques; Ketanserin; Male; Membrane Potentials; Metergoline; Neurons; Oxadiazoles; Picrotoxin; Piperazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Synaptic Transmission; Tryptamines | 1998 |
Evidence that acute serotonergic activation potentiates the locomotor-stimulating effects of corticotropin-releasing hormone in juvenile chinook salmon (Oncorhynchus tshawytscha).
Topics: Animals; Behavior, Animal; Corticotropin-Releasing Hormone; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluoxetine; Male; Piperazines; Salmon; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Swimming | 2003 |
Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Animals, Newborn; Anxiety Disorders; CREB-Binding Protein; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Exploratory Behavior; Feeding Behavior; Fluoxetine; Gene Expression Regulation, Enzymologic; Hippocampus; Indazoles; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type I; Phosphorylation; Piperazines; Reaction Time; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 2010 |
Plurality of anxiety and depression alteration mechanism by oleanolic acid.
Topics: alpha-Methyltyrosine; Animals; Anti-Anxiety Agents; Antidepressive Agents; Brain; Brain-Derived Neurotrophic Factor; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Fenclonine; Fluoxetine; Hippocampus; Imipramine; Male; Mice; Monoamine Oxidase; Motor Activity; Oleanolic Acid; Pentylenetetrazole; Piperazines; Pyridines | 2014 |